BioCentury
ARTICLE | Company News

Accelr8 Technology, Novartis deal

July 11, 2011 7:00 AM UTC

Novartis' Novartis Vaccines and Diagnostics Inc. subsidiary exercised an option to continue the technology evaluation program of Accelr8's BACcel rapid diagnostic system in identifying the type and qu...